These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15346097)

  • 41. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes and hypertension: the scope of the problem.
    Galvan AQ; Haffner SM; Ferrannini E
    Blood Press Suppl; 1996; 1():7-9. PubMed ID: 9162443
    [No Abstract]   [Full Text] [Related]  

  • 43. The renin angiotensin system as a therapeutic target to prevent diabetes and its complications.
    Vijayaraghavan K; Deedwania PC
    Cardiol Clin; 2005 May; 23(2):165-83. PubMed ID: 15694745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiological aspects of prediabetes--review of the current data.
    Zargar AH; Bashir MI
    J Indian Med Assoc; 2005 Nov; 103(11):591-3. PubMed ID: 16570761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Macro- and microvascular disease in type 2 diabetes mellitus].
    Cases A
    Nefrologia; 2002; 22(5):406-11. PubMed ID: 12497740
    [No Abstract]   [Full Text] [Related]  

  • 46. [Coronary artery disease in diabetic patients].
    Henry P
    Rev Prat; 2008 Sep; 58(14):1561-4. PubMed ID: 18839684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The proinflammatory and hypercoagulable state of diabetes mellitus.
    Aras R; Sowers JR; Arora R
    Rev Cardiovasc Med; 2005; 6(2):84-97. PubMed ID: 15976731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathophysiology and pharmacological treatment of insulin resistance.
    Matthaei S; Stumvoll M; Kellerer M; Häring HU
    Endocr Rev; 2000 Dec; 21(6):585-618. PubMed ID: 11133066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving control of diabetic risk factors in primary care settings.
    Bertoni AG
    Am J Manag Care; 2001 Apr; 7(4):411-21; quiz 422-3. PubMed ID: 11310195
    [No Abstract]   [Full Text] [Related]  

  • 51. [Diabetes mellitus and cerebrovascular disorders].
    Udaka F
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():336-41. PubMed ID: 12430250
    [No Abstract]   [Full Text] [Related]  

  • 52. [Type II diabetes and hypertension].
    Peters A; Kerner W
    Med Klin (Munich); 1996 Oct; 91(10):640-5. PubMed ID: 9019641
    [No Abstract]   [Full Text] [Related]  

  • 53. [How many diabetic patients are there in France?].
    Passa P
    Diabetes Metab; 1999 Sep; 25(4):366-7. PubMed ID: 10566129
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hypertensive heart disease and noninsulin-dependent diabetes mellitus: modern strategies in antihypertensive therapy].
    Barsukov AV; Talantseva MS
    Voen Med Zh; 2013 Sep; 334(9):46-53. PubMed ID: 24341203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes and hypertension physiopathology and therapeutics.
    Contreras F; Rivera M; Vasquez J; De la Parte MA; Velasco M
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S26-31. PubMed ID: 10854077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy].
    Berges K; Ritz E
    Dtsch Med Wochenschr; 1995 Feb; 120(7):225-6. PubMed ID: 7859647
    [No Abstract]   [Full Text] [Related]  

  • 57. Hypertension in people with diabetes and the metabolic syndrome: pathophysiologic insights and therapeutic update.
    Ganne S; Arora SK; Dotsenko O; McFarlane SI; Whaley-Connell A
    Curr Diab Rep; 2007 Jun; 7(3):208-17. PubMed ID: 17547838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving the pathway from cardiovascular medication prescribing to longer-term adherence: new results about old issues.
    Choudhry NK
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):223-5. PubMed ID: 20484200
    [No Abstract]   [Full Text] [Related]  

  • 59. Blood pressure control in type 2 diabetic patients.
    Grossman A; Grossman E
    Cardiovasc Diabetol; 2017 Jan; 16(1):3. PubMed ID: 28056987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Insulin resistance and its involvement in multiple risk factors associated with type 2 diabetes mellitus].
    Serrano Rios M; Ascaso Gimilio JF; Blázquez Fernández E; Cabezas Cerraro J; Carmena Rodríguez R; Escobar Jiménez F; Fernández-Real JM; Gabriel Sánchez R; Gomis de Barberá R; Grande Aragón C; Herrera Pomba JL; Pallardo Sánchez LF; Potau Vilalta N; Ricart Engel W; Rovira Loscos A; Zorzano Olarte A;
    Med Clin (Barc); 2002 Oct; 119(12):458-63. PubMed ID: 12385655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.